Novosis Overview

  • Founded
  • 1997
  • Status
  • Acquired/​Merged
  • Employees
  • 213
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $71.2M
Latest Deal Amount

Novosis General Information


Provider of transdermal and implantable drug delivery systems. The company specializes in the development and production of transdermal therapeutic systems and subcutaneous implants for drug application.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Other Devices and Supplies
Primary Office
  • Carl Feichtner Ring 1
  • 83714 Miesbach
  • Germany
+49 08025 00000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novosis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 31-Mar-2008 $71.2M 00000 Completed Profitable
2. Later Stage VC 10-Mar-2006 Completed Generating Revenue
1. Early Stage VC 01-Jan-2001 Completed Startup
To view Novosis’s complete valuation and funding history, request access »

Novosis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novosis Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
SHS Gesellschaft fur Beteiligungsmanagement Growth/Expansion Minority 000 0000 000000 0
To view Novosis’s complete investors history, request access »